TRPM3 and epilepsy: Patients with DEE-associated TRPM3 mutations exhibit a spectrum of neurological and developmental symptoms, including global developmental delay, epilepsy, altered pain perception, and cerebellar abnormalities such as ataxia and hypotonia.